4.87% More Zimmer Biomet Holdings Inc (NYSE:ZBH) Shorted Shares

June 29, 2018 - By Mike Johnson

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Corporate Logo

Zimmer Biomet Holdings Inc (NYSE:ZBH) had an increase of its short interest by 4.87%. FINRA published in June ZBH’s total 3.56 million short interest. That’s 4.87% up from 3.40 million shares. Zimmer Biomet Holdings Inc (NYSE:ZBH) has 1.58 million shares average volume. It’ll cost 2 days for ZBH to restore its previous position. Float short on Zimmer Biomet Holdings Inc is 1.76%.

ZBH hit $112.92 during the last trading session after $1.65 change.Currently Zimmer Biomet Holdings, Inc. is downtrending after 6.89% change in last June 29, 2017. ZBH has 268,906 shares volume. The stock underperformed the S&P500 by 19.46%.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, makes, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.The company has $22.95 billion market cap. It operates through four divisions: Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic , and Dental.13.65 is the P/E ratio. The firm provides orthopedic reconstructive products, such as knee and hip reconstructive products; S.E.T. products, including surgical, sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest.

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Ratings Coverage

In total 17 analysts cover Zimmer Biomet Holdings (NYSE:ZBH). “Buy” rating has 11, “Sell” are 1, while 5 are “Hold”. 65% are bullish. 22 are the (NYSE:ZBH)’s analyst reports since January 4, 2018 according to StockzIntelligence Inc. In Friday, April 27 report JMP Securities maintained it with “Market Outperform” rating and $133 target. In Wednesday, January 31 report Guggenheim maintained the stock with “Buy” rating. On Friday, April 27 the stock of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) has “Buy” rating given by Needham. On Monday, February 26 the rating was maintained by Morgan Stanley with “Overweight”. The stock rating was downgraded by Argus Research to “Hold” on Friday, June 22. The stock rating was maintained by Leerink Swann with “Outperform” on Wednesday, January 31. On Tuesday, January 30 the firm has “Buy” rating given by BMO Capital Markets. On Wednesday, January 31 the rating was upgraded by Stifel Nicolaus to “Buy”. In Tuesday, January 30 report Needham maintained the stock with “Buy” rating. On Tuesday, February 27 Citigroup maintained the shares of ZBH in report with “Neutral” rating.

A couple more Zimmer Biomet Holdings, Inc. (NYSE:ZBH) news were announced by: Seekingalpha.com which released on June 27, 2018 “Medical device makers ISRG, BSX, ABT started with bullish view at Bernstein”, also Benzinga.com on June 22, 2018 announced “Argus Drops Bullish Zimmer Biomet Thesis On Manufacturing, Supply, Sales Worries”, the next Benzinga.com is “Benzinga’s Top Upgrades, Downgrades For June 22, 2018” on June 22, 2018. Benzinga.com has article titled “Benzinga’s Bulls & Bears Of The Week: AMD, Disney, Nike, Tesla And More”.

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.